Policy, Commissioning and Managerial
49 results
Applied filters
Controlled drugs governance for dental teams
16 March 2026This article explains controlled drug (CD) governance arrangements dental teams should have, such as a CD lead and comprehensive SOPs.
Managing controlled drugs waste for dental teams
16 March 2026Controlled drugs (CDs) in Schedules 2, 3, and 4(1) should be denatured before disposal as pharmaceutical waste. An Environment Agency T28 exemption is required.
Storing and recording controlled drugs for dental teams
16 March 2026Storage and record-keeping for controlled drugs must comply with legislation. What is required varies depending on the Schedule a drug belongs to.
Managing controlled drugs held as stock for dental teams
16 March 2026Stock schedule 2 and 3 controlled drugs (CDs) must be ordered (requisitioned) on Form FP10CDF. Schedule 4 and 5 CDs can be ordered the same way as non-CDs.
Prescribing controlled drugs for dental teams
16 March 2026This article explains which controlled drugs (CDs) dentists may prescribe, how to prescribe them, and on which forms.
Managing controlled drugs for dental teams
16 March 2026This article provides an overview of controlled drug (CD) management for dental teams
Understanding when a check adds value to medication processes
20 February 2026Understanding what a check is, the principles of an effective check and factors to consider if introducing a check to a medication process.
Medicines Procurement and Supply Chain (MPSC) frameworks
19 February 2026Procurement of medicines and services is undertaken nationally in England by Medicines Procurement and Supply Chain (MPSC) frameworks.
Procurement of medicines and services for NHS secondary care
19 February 2026An overview of procurement arrangements for medicines and pharmaceutical products and services for NHS secondary care providers in England.
Procurement of branded medicines within the tranche system
19 February 2026The Medicines Procurement and Supply Chain (MPSC) uses a tranche system for procurement of branded medicines within the same treatment area.